[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS59184181A - 3,8-di(1,2-dihydroxyethyl)deuteroporphyrin - Google Patents

3,8-di(1,2-dihydroxyethyl)deuteroporphyrin

Info

Publication number
JPS59184181A
JPS59184181A JP5614383A JP5614383A JPS59184181A JP S59184181 A JPS59184181 A JP S59184181A JP 5614383 A JP5614383 A JP 5614383A JP 5614383 A JP5614383 A JP 5614383A JP S59184181 A JPS59184181 A JP S59184181A
Authority
JP
Japan
Prior art keywords
dihydroxyethyl
deuteroporphyrin
protoporphyrin
laser
hematoporphyrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5614383A
Other languages
Japanese (ja)
Inventor
Haruo Sato
井戸健一
Kenichi Ido
佐藤治男
Rooi Tsujimoto
辻本ローイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SATO YAKUGAKU KENKYUSHO KK
Original Assignee
SATO YAKUGAKU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SATO YAKUGAKU KENKYUSHO KK filed Critical SATO YAKUGAKU KENKYUSHO KK
Priority to JP5614383A priority Critical patent/JPS59184181A/en
Publication of JPS59184181A publication Critical patent/JPS59184181A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:3,8-Di(1,2-dihydroxyethyl)deuteroporphyrin shown by the formula and its salt. USE:Useful as a laser photosensitizer having affinity for tumor. Synthesizable purely and easily. PREPARATION:A protoporphyrin dialkyl ester is reacted with osmium tetroxide to give an addition product, which is hydrolyzed, so that two vinyl group of the protoporphyrin dialkyl ester is converted into a dioxy derivative, which is de- esterifed by hydrolysis, to give a compound shown by the formula.

Description

【発明の詳細な説明】 本発明は新規なポルフィリン化合物、更に詳細には次式
(1)、 で表わされる3、8−ジ(1,2−ジハイドロオキシエ
チル)デュウテロボルフイリン及びその塩に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel porphyrin compounds, more specifically, 3,8-di(1,2-dihydroxyethyl) deuteroborphyrin represented by the following formula (1) and salts thereof. Regarding.

近年レーザーの医療への応用が活発に行われており%特
に癌の治療及び診断においてその進歩は顕著である。そ
の中でも、Doughert)らはヘマトポルフィリン
誘導体とアルゴン色素レーザーとの組合せで癌の早期発
見と治療に大きな成果をあけている。すなわち、レーザ
ーの生体組織内への進達度及び直行性を利用し、ヘマト
ポルフィリン誘導体のような腫瘍親和性のある光増感物
質を予め投与して腫瘍に蓄積させておき、レーザー照射
によって腫瘍の有無を診断すると共に、その部位を低エ
ネルギーのアルゴン色素レーザー照射いて選択的に破壊
するものである。
In recent years, lasers have been actively applied to medical treatments, and their progress has been particularly remarkable in the treatment and diagnosis of cancer. Among them, Doughert et al. have achieved great results in the early detection and treatment of cancer by combining hematoporphyrin derivatives and argon dye lasers. That is, by utilizing the degree of penetration and orthogonality of the laser into living tissue, a photosensitizer with tumor affinity such as hematoporphyrin derivatives is administered in advance and accumulated in the tumor, and the tumor is stimulated by laser irradiation. In addition to diagnosing the presence or absence of the disease, the site is selectively destroyed by irradiating the affected area with a low-energy argon dye laser.

このように光増感物質を投与して癌の治療を行うことは
、古くから紫外線又は放射線治療において行われてきた
が、近年レーザーの出現により、腫瘍親和性のあるレー
ザー光増感物質の開発が脚光を浴びてきた。
Treatment of cancer by administering photosensitizers in this way has been carried out in ultraviolet or radiation therapy for a long time, but in recent years, with the advent of lasers, the development of laser photosensitizers with tumor affinity. has been in the spotlight.

D、Kes+selらは種々のポルフィリン化合物につ
いて、腫瘍親和性とレーザー光増感作用を検討し、ヘマ
トポルフィリンを提供した。しかし、ヘマトポルフィリ
ンは、Dolphin著、’ Th@Porphyri
ns”、”tlol 1.アカテミツクプレス発亘、1
978年、第297〜298頁、に示されているように
、純粋なものを得るのが困難であり、前述のDough
ettyらの研究に)おいて使用されているものも数種
のへマドポルフィリン様物質の混合物である。このこと
は基礎研究を行う上で、また臨床に応用する場合の大き
な障害となっていた。
D. Kes+sel et al. investigated the tumor affinity and laser photosensitization effect of various porphyrin compounds, and provided hematoporphyrin. However, hematoporphyrin, written by Dolphin, 'Th@Porphyri
ns”,”tlol 1. Launched by Akatemic Press, 1
978, pp. 297-298, it is difficult to obtain a pure product, and the above-mentioned Dough
The one used in the study by etty et al.) is also a mixture of several hematoporphyrin-like substances. This has been a major obstacle in conducting basic research and in applying it to clinical practice.

そこで、本発明者は、ヘマトポルフィリンと同様な腫瘍
親和性を有し、純粋にしかも容易に合成できるポルフィ
リン化合物を提供すべく鋭意研究を行った結果、本発明
を完成した。
Therefore, the present inventor conducted intensive research to provide a porphyrin compound that has tumor affinity similar to that of hematoporphyrin and can be easily synthesized in a pure manner, and as a result, completed the present invention.

すなわち、本発明は、腫瘍親和性を有するレーザー光゛
増感剤として有用な(1)式で表わされる3、8−ジ(
1,2−ジ/・イドロオキシエチル)デュウテロポルフ
イリン及びその塩を提供するものである。
That is, the present invention provides a 3,8-di(
The present invention provides 1,2-di/-idroxyethyl) deuteroporphyrin and salts thereof.

本発明os 、s−ジ<1*2−ジノ・イトロオキシエ
チル)デュウテロボルフイリン(1)は、例えばプロト
ポルフィリンジアルキルエステルに四酸化オスミウムを
反応させ、次いで得られる付加物を加水分解してプロト
ポルフィリンジアルキルエステルの2つのビニル基をジ
オキシ体となし、更に加水分解によって脱エステル化す
ることによ沙製造される。
The os, s-di<1*2-dino-itroxyethyl) deuteroborphyrin (1) of the present invention can be produced, for example, by reacting protoporphyrin dialkyl ester with osmium tetroxide and then hydrolyzing the resulting adduct. It is produced by converting two vinyl groups of a protoporphyrin dialkyl ester into dioxy forms and then de-esterifying it by hydrolysis.

このようにして得られる本発明化合物(1)はへマドポ
ルフィリンと同様な物性、すなわち水あるいは緩衝液に
対し同等な溶解性を示し、405 amで励起するとき
同等の螢光強度が観測される。また、実施例2に示すよ
うに、癌細胞に対する親和性もヘマトポルフィリンのそ
れと同等である。
The compound (1) of the present invention obtained in this manner exhibits physical properties similar to those of hematoporphyrin, that is, it exhibits the same solubility in water or buffer solutions, and the same fluorescence intensity is observed when excited at 405 am. . Moreover, as shown in Example 2, the affinity for cancer cells is also equivalent to that of hematoporphyrin.

次に実施例を埜けて説明する。Next, an explanation will be given with reference to examples.

実施例1 (1)  グロトボルフイリンジメチルエステル1tを
ピリジン20−に溶かし、これにジエチルエーテル30
0−を加え、攪拌下これに四酸化オスミウム1tのジエ
チルエーテル溶液1001111!を滴加した。室温で
1時間反応を行い、析出した沈澱を炉取した。これを5
%塩酸を含むメタノール1001R1に溶かし、2時間
加熱還流後、反応液を濾過し、ろ液をアンモニア水で中
和した。析出物を炉取、乾燥しく0.76F’)、これ
をメチレンクロライドに温時溶解し、シリカゲルクロマ
トグラフィーで精製して生成物0.45tを得た。融点
228〜230℃(分解)。
Example 1 (1) Dissolve 1 t of glotoborophyllin dimethyl ester in 20% of pyridine, and add 30% of diethyl ether to this.
1001111 of a diethyl ether solution of 1 ton of osmium tetroxide is added to the solution under stirring. was added dropwise. The reaction was carried out at room temperature for 1 hour, and the deposited precipitate was collected in a furnace. This is 5
The reaction mixture was dissolved in methanol 1001R1 containing % hydrochloric acid, heated under reflux for 2 hours, and then the reaction solution was filtered, and the filtrate was neutralized with aqueous ammonia. The precipitate was collected in an oven and dried (0.76 F'), dissolved in methylene chloride at warm temperature, and purified by silica gel chromatography to obtain 0.45 t of product. Melting point 228-230°C (decomposition).

この生成物は元素分析、NMR,IRにより分析した結
果、3,8−ジ(1,2−ジハイドロオキシメチル)デ
ュウテロボルフイリンジメチルエステルであることが確
認された。
As a result of elemental analysis, NMR, and IR analysis, this product was confirmed to be 3,8-di(1,2-dihydroxymethyl) deuteroborphyrin dimethyl ester.

元素分析値: 計算値%: c 65.64 a H6,43、H8,
jl実側値%: C65,73、H6,40、H8,5
5IH−NMR(ds−ピリジンの10%溶液)δ3.
40(4H,m、13−I  CHz117−I  C
H2)、3−50 (6H= m 、18 C)Ig 
、12 C)Is )、3.58(6H,l l 7C
H3)、3.68(3HI I # 2CHa  )、
3、80 (3H+ a + 7 CH3) 、4.8
 (2Ht m + 3−158−ICH)、5.I 
C2H,m、8−2CH2)、5.2(2H,a、3−
2CH2)、6.9(4n、b、−on)、10.30
(IH,s、150H)、10.47(1)I、a。
Elemental analysis value: Calculated value %: c 65.64 a H6,43, H8,
jl actual value %: C65,73, H6,40, H8,5
5IH-NMR (10% solution of ds-pyridine) δ3.
40 (4H, m, 13-I Chz117-I C
H2), 3-50 (6H=m, 18C)Ig
, 12 C) Is ), 3.58 (6H, l l 7C
H3), 3.68 (3HI I # 2CHa),
3,80 (3H+a+7CH3),4.8
(2Ht m + 3-158-ICH), 5. I
C2H, m, 8-2CH2), 5.2 (2H, a, 3-
2CH2), 6.9 (4n, b, -on), 10.30
(IH, s, 150H), 10.47(1) I, a.

20 CH)、11.18 (in、s −10cH)
、11−23(in、s、5CH)。
20 CH), 11.18 (in, s -10cH)
, 11-23 (in, s, 5CH).

(i)  上記に)で得たジメチルエステル0.3f’
tピリジン100−に溶かし、苛性ソーダ45■のメタ
ノール溶液を加え、2時間70℃で攪拌した。反応後、
析出結晶を炉取し、ピリジン、ジクロルエタン、アセト
ンで順次洗浄後、乾燥して、3,8−ジ(1,2−ジハ
イドロオキシエチル)デュウテロホルフイリン・ジナト
リウム0.3fを得た。
(i) 0.3f' of dimethyl ester obtained in above)
The mixture was dissolved in 100% of pyridine, added with a methanol solution of 45 μm of caustic soda, and stirred at 70° C. for 2 hours. After the reaction,
The precipitated crystals were collected in a furnace, washed successively with pyridine, dichloroethane, and acetone, and then dried to obtain 0.3f of 3,8-di(1,2-dihydroxyethyl) deuterophorphyrin disodium.

UVスペクトル H9 λ  nm(emM):395(148,43)、so
sm&X (5,60)、539(3,91)、565(3,37
)615(1,42)。
UV spectrum H9 λ nm (emM): 395 (148,43), so
sm&X (5,60), 539 (3,91), 565 (3,37
)615(1,42).

11N−H2s0’  nm(smM):403(33
0,60)、550(1187)、592(4,31)
11N-H2s0' nm (smM): 403 (33
0,60), 550 (1187), 592 (4,31)
.

実施例2 DAB誘導ラット腹水肝癌(AH−7974)由来の株
化培養細胞(JTC−16)をDM −170培地にて
37℃で培養し、対数増殖期中期にヘマトポルフィリン
(HPD )又は3゜8−ジ(1,2−ジハイドロオキ
シエチル)デュウテロボルフイリン・ジナトリウム(0
HDP Na2 )を加え、24時間インキュベートし
た後、5 mW / cm2 のエネルギーで波長48
8 nmのアルゴンレーザーを照射した。
Example 2 A cultured cell line (JTC-16) derived from DAB-induced rat ascites liver cancer (AH-7974) was cultured in DM-170 medium at 37°C, and in the mid-logarithmic growth phase, hematoporphyrin (HPD) or 3°C 8-di(1,2-dihydroxyethyl) deuteroborphyrin disodium (0
HDP Na2) was added and after incubation for 24 hours, the energy of 5 mW/cm2 was applied at wavelength 48.
It was irradiated with an 8 nm argon laser.

その結果、無添加細胞は3分間のレーザー照射で変化は
認められなかった。HPDの場合は15μt/lntの
濃度でレーザー照射なしてインキュベートしても変化は
なかったが、レーザー照射を1分間行ったところ細胞は
変化した。また0HDPNa*の場合は20μt/−湿
度テレーザー照射なして゛インキユベートシテモ変化は
なかったが、レーザー照射1公″l1kK細胞は変化し
た。
As a result, no change was observed in the additive-free cells after 3 minutes of laser irradiation. In the case of HPD, there was no change even if the cells were incubated at a concentration of 15 μt/lnt without laser irradiation, but when laser irradiation was performed for 1 minute, the cells changed. In the case of 0HDPNa*, there was no change in the incubation temperature without irradiation with the 20 μt/-humidity telelaser, but there was a change in the 11kK cells exposed to the laser.

以上の結果から癌細胞に対する親和性はHPD及び0H
DPNa2においてtlは同等であった。
From the above results, the affinity for cancer cells is HPD and 0H.
tl was comparable in DPNa2.

Claims (1)

【特許請求の範囲】[Claims] で表わされる3、8−ジ(1,2−ジノーイドロオキシ
エチル)デュウテロポルフイリン及びその塩。
3,8-di(1,2-dinoidroxyethyl)deuteroporphyrin and its salt.
JP5614383A 1983-03-31 1983-03-31 3,8-di(1,2-dihydroxyethyl)deuteroporphyrin Pending JPS59184181A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5614383A JPS59184181A (en) 1983-03-31 1983-03-31 3,8-di(1,2-dihydroxyethyl)deuteroporphyrin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5614383A JPS59184181A (en) 1983-03-31 1983-03-31 3,8-di(1,2-dihydroxyethyl)deuteroporphyrin

Publications (1)

Publication Number Publication Date
JPS59184181A true JPS59184181A (en) 1984-10-19

Family

ID=13018852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5614383A Pending JPS59184181A (en) 1983-03-31 1983-03-31 3,8-di(1,2-dihydroxyethyl)deuteroporphyrin

Country Status (1)

Country Link
JP (1) JPS59184181A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220686A2 (en) * 1985-10-23 1987-05-06 Nihon Medi-Physics Co., Ltd. Porphyrin derivatives, and their production and use
JPH0413275U (en) * 1990-05-17 1992-02-03

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220686A2 (en) * 1985-10-23 1987-05-06 Nihon Medi-Physics Co., Ltd. Porphyrin derivatives, and their production and use
JPH0413275U (en) * 1990-05-17 1992-02-03

Similar Documents

Publication Publication Date Title
EP0233701B1 (en) Porphyrin derivatives
JP6910551B2 (en) Photosensitizers, their derivatives and applications
EP0322795B1 (en) Novel tetrapyrrole aminocarboxylic acids
NO169290B (en) ANALOGY PROCEDURE FOR PREPARING A THERAPEUTIC ACTIVE TETRAPYRROL-AMINO-DICARBOXYLIC ACID ADD
KR102245556B1 (en) Novel chlorine e6 derivative and pharmaceutically acceptable salt thereof, preparation method and application thereof
CN109456352B (en) Phenylboronic acid ester modified hydrogen peroxide activated type boron dipyrromethene photosensitizer and preparation thereof
CN114045045B (en) Single-photon up-conversion pentamethine cyanine photosensitive dye, and preparation method and application thereof
CN113683602B (en) Heptamethine cyanine micromolecule for multi-modal treatment of hypoxic tumors, and preparation method and application thereof
Li et al. BODIPY-based photocages: rational design and their biomedical application
CN112409365B (en) 3-sulfopropane sulfydryl modified phthalocyanine, preparation method thereof and application thereof in pharmaceutical field
CN113384695B (en) Pentamethyl cyanine dye photosensitive dye with long excited state life, preparation method and application thereof
CN113461740B (en) Iridium complex and preparation method and application thereof
US4709022A (en) Pheophorbide derivatives and alkaline salts thereof
JPS6092287A (en) 9-desoxo-9-hydroxy-pheophorbide derivative and its alkali metal salt
JPS59184181A (en) 3,8-di(1,2-dihydroxyethyl)deuteroporphyrin
CN110423260B (en) Glucose-modified cyclometalated iridium photosensitizer and preparation method and application thereof
JPS62249986A (en) Porphyrin derivative
CN114409687B (en) Photosensitive medicine capable of switching light treatment modes in tumor and preparation method and application thereof
EP1250339B1 (en) Porphyrins and related compounds
CN106083872B (en) Purpurin 18 ether derivative and its preparation method and application
WO2001040234A1 (en) Porphyrin compound
CN112028871B (en) Lysosome targeted photosensitizer, synthetic method and application in biological imaging
CN114656453A (en) Heptamethine indole cyanine-TEMPO chemical couple chain small molecule, preparation method and application thereof in preparing radioprotection preparation
JPH0786109B2 (en) Pheophorbide derivative
CN113603698A (en) Phthalocyanine-perphenazine conjugate with type I photosensitive reaction and photothermal synergistic effect and application in pharmaceutical field